Management of fever in Australian children: a population-based sample survey
verfasst von:
Joanna Holt, Leslie White, Gavin R. Wheaton, Helena Williams, Shefali Jani, Gaston Arnolda, Hsuen P. Ting, Peter D. Hibbert, Jeffrey Braithwaite, on behalf of the CareTrack Kids investigative team
Fever in childhood is a common acute presentation requiring clinical triage to identify the few children who have serious underlying infection. Clinical practice guidelines (CPGs) have been developed to assist clinicians with this task. This study aimed to assess the proportion of care provided in accordance with CPG recommendations for the management of fever in Australian children.
Methods
Clinical recommendations were extracted from five CPGs and formulated into 47 clinical indicators for use in auditing adherence. Indicators were categorised by phase of care: assessment, diagnosis and treatment. Patient records from children aged 0 to 15 years were sampled from general practices (GP), emergency departments (ED) and hospital admissions in randomly-selected health districts in Queensland, New South Wales and South Australia during 2012 and 2013. Paediatric nurses, trained to assess eligibility for indicator assessment and adherence, reviewed eligible medical records. Adherence was estimated by individual indicator, phase of care, age-group and setting.
Results
The field team conducted 14,879 eligible indicator assessments for 708 visits by 550 children with fever in 58 GP, 34 ED and 28 hospital inpatient settings. For the 33 indicators with sufficient data, adherence ranged from 14.7 to 98.1%. Estimated adherence with assessment-related indicators was 51.3% (95% CI: 48.1–54.6), 77.5% (95% CI: 65.3–87.1) for diagnostic-related indicators and 72.7% (95% CI: 65.3–79.3) for treatment-related indicators. Adherence for children < 3 months of age was 73.4% (95% CI: 58.0–85.8) and 64.7% (95% CI: 57.0–71.9) for children 3–11 months of age, both significantly higher than for children aged 4–15 years (53.5%; 95% CI: 50.0–56.9). The proportion of adherent care for children attending an ED was 77.5% (95% CI: 74.2–80.6) and 76.7% (95% CI: 71.7–81.3) for children admitted to hospital, both significantly higher than for children attending a GP (40.3%; 95% CI: 34.6–46.1).
Conclusions
This study reports a wide range of adherence by clinicians to 47 indicators of best practice for the management of febrile children, sampled from urban and rural regions containing 60% of the Australian paediatric population. Documented adherence was lowest for indicators related to patient assessment, for care provided in GP settings, and for children aged 4–15 years.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AGREE II
Appraisal of Guidelines for Research & Evaluation tool
CPG
clinical practice guideline
CTK
CareTrack Kids study
ED
emergency departments
FEVE11; FEVE37; FEVE35–37
Quality indicator identifications for fever
GP
general practices
SURVEYFREQ
name of the SAS procedure used for sample survey data
Background
Fever is a common acute presentation in childhood, recently estimated to contribute 15–25% of consultations in primary care and emergency departments (EDs) [1]. Although raised body temperature has a number of causes it is most often associated with infection, the aetiology of which has continued to evolve alongside immunisation regimes [1‐5].
In Australia, children with a fever may be seen by a GP, occasionally by a specialist paediatrician, or they may present to a hospital ED. A 2012 retrospective analysis found that 7.2% of febrile children under 5 years of age who presented to a specialist Australian children’s hospital had a serious bacterial infection, comprising: urinary tract infections (3.4%); pneumonia (3.4%); bacteraemia (0.4%); osteomyelitis (0.08%); meningitis (0.05%); and septic arthritis (0.04%) [6].
Anzeige
Most children present as mildly unwell, so the key challenge for clinicians is to quickly triage those few with serious underlying infections who are at risk of deterioration, whilst avoiding over-investigation and over-medication of the many children whose fever will resolve and only require symptomatic support and reassurance. Clinical practice guidelines (CPGs), prediction rules and pathways aim to assist clinician judgement in distinguishing self-limiting viral conditions from more serious illnesses, including life-threatening sepsis, and in managing care appropriately.
The CareTrack Kids (CTK) study retrospectively assessed care provided to a sample of Australian children aged 0–15 years, in 2012 and 2013, to determine the proportion who received care in line with CPG recommendations for 17 common conditions [7]. The proportion of care provided in accordance with CPG recommendations (adherent care) across all the 17 conditions averaged 59.8% (95% CI: 57.5–62.0) [7]. This report presents the CTK findings for children presenting with fever.
Methods
The CTK methods have been described in detail elsewhere [7‐9]. We further describe some aspects specifically relevant to fever.
Development of indicators
A systematic search was conducted for Australian and international CPGs relating to fever in children published from 2005 to 2013. This search yielded one international guideline from the UK [10], one from a US paediatric hospital [11], one from an Australian paediatric hospital [12] and two from Australian state health entities [13, 14]. From these five CPGs, 87 recommendations were extracted and assessed for inclusion with 39 draft recommendations selected for review. During internal and external expert review, recommendations were excluded due to low acceptability, feasibility, or impact; if the concept was covered in other recommendations(s); or rated with a low appropriateness score by reviewers [9].
Anzeige
Thirteen recommendations were retained after review, and these were formatted into 47 medical record audit questions, hereafter referred to as ‘indicators’. Of those, 21 were restricted to specific age-groups, and 15 were restricted to specific settings (four to GPs, six to ED presentations, three to either ED presentations or inpatients, and two to either GP or ED presentations). Indicators were categorised as indicating underuse or overuse. Details of all indicators are shown in Additional file 1: Table S1.
Sampling strategy
CTK targeted 400 medical records for fever and 6000 medical records for 16 other common childhood conditions. If any of the 6400 targeted medical records contained care for fever, a separate assessment of adherent care was made for each visit. Detail on the general sampling methods are provided elsewhere [7]; additional details specific to fever can be found in Additional file 2. Briefly, four settings were sampled: hospital inpatients, ED presentations, and consultations at GPs and paediatricians’ offices in the community. These care settings were located in randomly-selected health administrative districts in Queensland, New South Wales and South Australia. Figure 1 illustrates the breakdown of assessment settings by state.
Fig. 1
Fever assessments by state and health care provider type. Total number of visits to Emergency Departments = 393; total number of admissions to hospital = 98; total number of visits to General Practitioners = 217. Total number of fever assessments in: New South Wales = 303; Queensland = 227; and South Australia = 178. Total number of visits assessed for care of fever in sampling frame = 708. [Adapted from https://mapchart.net/, CC BY-SA 4.0]
×
Eligible children were those aged ≤15 years who received care in 2012 and 2013. For care of fever, only one visit to a paediatrician was sampled, so this setting was removed prior to analysis. For the CTK study, the recruitment rate was 92% for hospitals, and was estimated to be 24% for GPs (Additional file 2). Nine experienced paediatric nurses, trained to assess eligibility for indicator assessment and adherence to CPGs, collected data. Medical records for selected visits in 2012 and 2013 were reviewed on-site at each participating facility during March–October 2016.
Data analysis
Adherence was measured as the percentage of responses for each eligible indicator (i.e. answered ‘Yes’ or ‘No’) which was scored as ‘Yes’. Sampling weights were constructed as specified in Additional file 2 to adjust for oversampling of states and some settings, and for sampling within health districts [7]. The weighted data were analysed using SAS software, Version 9.4 (SAS Institute Inc., North Carolina, USA), using the SURVEYFREQ procedure. Variance was estimated by Taylor series linearization and the primary sampling unit (health district) was specified as the clustering unit. Stratification and, where appropriate, domain analyses were used (Additional file 2). Exact 95% CIs were generated using the modified Clopper-Pearson method. Results were suppressed if there were < 25 assessments.
Results were analysed for each indicator by age and grouped into phases of care relevant to the fever condition: ‘Assessment’ (documentation of relevant clinical history, signs and symptoms), ‘Diagnostics’ (any tests or investigations undertaken) and ‘Treatment’ (any therapy administered, including ongoing care and advice). Four age groups were chosen based on presumed risk differences and alignment with age group specific indicators: < 3 months; 3–11 months; 1–3 years; and 4–15 years. Phase of care results are not independent, as the same child generally has multiple phases of care in the one visit, so we report differences between point estimates but make no claims with respect to their statistical significance. Some non-contiguous age-group results (e.g., < 1 year vs > 3 years) and some settings (e.g., GPs vs hospital results) are independent and differences were compared statistically. Results were also analysed according to the setting of care.
Ethical considerations
Primary ethics approval was received from relevant bodies including the Royal Australian College of General Practitioners (NREEC 14–008) and state hospital networks (HREC/14/SCHN/113; HREC/14/QRCH/91; HREC/14/WCHN/68), and site-specific approvals from 34 sites. All relevant bodies provided approval to waive requirements for patient consent for external access to medical records [8]. Ethics approvals included reporting by healthcare setting type for condition-level data. Participants were protected from litigation by gaining statutory immunity for CTK as a quality assurance activity, from the Federal Minister for Health under Part VC of the Health Insurance Act 1973 (Commonwealth of Australia).
Results
Medical records reviewed
Details of the 550 children with one or more visits for fever are provided in Table 1. Almost three-quarters of the children in the sample were under 4 years of age, with more males (56.2%) than females. Each child had 1–6 fever visits (median = 1).
Table 1
Characteristics of the children with fever, 2012–2013
Characteristic
Children in the CTK Study
Agea - no. (%)
< 3 months
36 (6.5)
3–11 months
104 (18.9)
1–3 years
259 (47.1)
4–15 years
151 (27.5)
Sex - no. (%)
Male
309 (56.2)
Female
241 (43.8)
aThe child’s age was calculated as the age at visit where there was only one, or the midpoint of the child’s age at his first and last fever visit
Of 38,023 possible indicator assessments, 13,096 (34.4%) were automatically filtered by age, setting or both, and a further 10,048 (26.4%) were assessed as not applicable or otherwise ineligible. The field team conducted 14,879 eligible indicator assessments grouped into 708 visits, at a median of 22 indicators per visit. Fever visits were assessed in 58 GP (n = 217), 34 ED (n = 393) and 28 inpatient settings (n = 98).
Anzeige
Adherence
The estimated proportion of care adherent for each indicator is shown in Table 2. Adherence is not reported for 14 of the 47 indicators, as they had < 25 assessments. For the 33 indicators where results were reported, mean adherence was 53.5% (95% CI: 50.0–56.9) and ranged from 14.7% for indicator FEVE11 (presence of joint symptoms documented) to 98.1% for FEVE37 (infants aged < 3 months who presented to the ED had a urinalysis with culture performed). The median estimated adherence for the 33 reported indicators was 65.8% (interquartile range 39.8 to 85.1%).
Table 2
Adherence, by clinical indicator, 2012–2013
Indicator ID
Indicator Description
Phase of Care
No. of Children
No. of Visits
Proportion Adherent % (95% CI)
FEVE01
Children with a fever (over 38 °C) had all recent antibiotic treatment documented.
Assessment
544
699
45.9 (34.0, 58.1)
FEVE02
Neonates aged < 1 month with a fever (over 38 °C) had the GBS status of their mother documented.
Assessment
13
19
Insufficient data
FEVE03
Children with a fever (over 38 °C) had their fluid intake documented.
Assessment
548
704
53.3 (39.8, 66.4)
FEVE04
Children with a fever (over 38 °C) had their length of illness documented.
Assessment
549
707
90.4 (78.5, 97.0)
FEVE05
Children with a fever (over 38 °C) had any recent travel documented.
Assessment
548
702
16.3 (11.1, 22.8)
FEVE06
Children with a fever (over 38 °C) had their immunisation status documented.
Assessment
550
706
79.7 (66.8, 89.3)
FEVE07
Children with a fever (over 38 °C) had whether they were in direct contact with unwell people documented.
Assessment
550
706
29.0 (18.2, 42.0)
FEVE08
Children with a fever (over 38 °C) aged 4–15 years old had the presence of headaches documented.
Assessment
149
175
22.0 (5.8, 48.8)
FEVE09
Children with a fever (over 38 °C) had the presence of diarrhoea and vomiting documented.
Assessment
550
707
65.8 (59.1, 72.1)
FEVE10
Children with a fever (over 38 °C) had the presence of abdominal pain documented.
Assessment
549
705
59.3 (50.2, 67.9)
FEVE11
Children with a fever (over 38 °C) had the presence of joint symptoms documented.
Assessment
411
509
14.7 (9.5, 21.3)
FEVE12
Children with a fever (over 38 °C) had their alertness assessed.
Assessment
548
705
66.1 (56.2, 75.1)
FEVE13
Children with a fever (over 38 °C) had their vital signs assessed.
Assessment
550
708
45.9 (35.5, 56.7)
FEVE14
Children with a fever (over 38 °C) had their airway, breathing and any signs of stridor assessed.
Assessment
550
708
59.8 (44.4, 74.0)
FEVE15
Children with a fever (over 38 °C) had their circulation and capillary refill assessed.
Assessment
550
707
39.8 (32.4, 47.4)
FEVE16
Children with a fever (over 38 °C) had their cough assessed.
Assessment
549
706
61.8 (49.8, 72.9)
FEVE17
Children with a fever (over 38 °C) had their mucous membranes assessed.
Assessment
550
706
32.1 (24.4, 40.5)
FEVE18
Children with a fever (over 38 °C) aged 4–15 years old were assessed for photophobia.
Assessment
149
175
22.1 (4.2, 54.1)
FEVE19
Children with a fever (over 38 °C) were assessed for the presence of any neck stiffness.
Assessment
550
706
32.9 (23.6, 43.4)
FEVE20
Children with a fever (over 38 °C) were assessed for a rash.
Assessment
549
705
57.2 (48.3, 65.8)
FEVE21
Children with a fever (over 38 °C) were assessed for otitis media or received an examination of their eardrums.
Assessment
549
705
87.4 (74.3, 95.4)
FEVE22
Infants aged < 1 month presenting to the GP with a fever (over 38 °C) were referred to hospital.
Treatment
2
2
Insufficient data
FEVE23
Infants aged 0–3 months who presented with fever (over 38 °C) were referred to hospital.
Treatment
5
5
Insufficient data
FEVE24
Infants aged 0–3 months with a fever (over 38 °C) received a sepsis work-up.
Diagnostics
46
69
85.6 (66.1, 96.2)
FEVE25
Infants aged 0–1 months with a fever (over 38 °C) received parenteral antibiotics.
Treatment
27
42
85.1 (64.6, 96.2)
FEVE26
Children aged 3 months to 3 years with a fever (over 38 °C) who had no clear source of infection, appeared well and were fully immunised received urine microscopy.
Diagnostics
140
165
77.7 (63.9, 88.2)
FEVE27
Children aged 3 months to 3 years with a fever (over 38 °C) who had no clear source of infection, appeared well and were fully immunised were discharged home.
Treatment
133
147
92.4 (86.9, 96.1)
FEVE28
Parents of children aged 3 months to 3 years with a fever (over 38 °C) who had no clear source of infection, appeared well and were fully immunised were advised to have their child reviewed if they deteriorate.
Treatment
220
243
86.2 (73.9, 94.1)
FEVE29
Children aged ≥3 years with a fever (over 38 °C), no clinical focus and who were well were not prescribed antibiotics.
Treatment
111
126
78.8 (51.1, 95.0)
FEVE30
Infants and children who presented to ED with a fever (over 38 °C) who were shocked, unrousable OR showing signs of meningococcal disease received immediate antibiotics.
Treatment
17
17
Insufficient data
FEVE31
Infants and children who presented to ED with a fever (over 38 °C) and were shocked, unrousable OR showing signs of meningococcal disease received immediate fluid resuscitation.
Treatment
16
16
Insufficient data
FEVE32
Infants and children who presented to ED with a fever (over 38 °C) and were shocked, unrousable OR showing signs of meningococcal disease were referred or retrieved to a PICU.
Treatment
16
16
Insufficient data
FEVE33
Infants and children who presented to their GP with a fever (over 38 °C) and were shocked, unrousable OR showing signs of meningococcal disease received immediate antibiotics.
Treatment
4
4
Insufficient data
FEVE34
Infants and children who presented to their GP with a fever (over 38 °C) and were shocked, unrousable OR showing signs of meningococcal disease were transferred to hospital.
Treatment
3
3
Insufficient data
FEVE35
Infants aged < 3 months who presented to the ED with a fever (over 38 °C) had a CBE (with differential) and CRP performed.
Diagnostics
34
34
92.1 (77.5, 98.5)
FEVE36
Infants aged < 3 months who presented to the ED with a fever (over 38 °C) had blood cultures taken.
Diagnostics
34
34
96.4 (81.5, 99.9)
FEVE37
Infants aged < 3 months who presented to the ED with a fever (over 38 °C) had a urinalysis with culture performed.
Diagnostics
34
34
98.1 (86.4, 100)
FEVE38
Children with a fever (over 38 °C) who were toxic or unwell and had no focus of infection had a blood count (CBE) performed.
Diagnostics
167
215
75.2 (59.8, 87.0)
FEVE39
Children with a fever (over 38 °C) who were toxic or unwell and had no focus of infection had blood cultures taken at the same time as other blood tests.
Diagnostics
161
203
77.6 (61.8, 89.2)
FEVE40
Children aged 3 months to 3 years with a fever (over 38 °C) who showed signs of shock and had no clear source of infection had a venous blood gas taken.
Diagnostics
16
20
Insufficient data
FEVE41
Children aged 3 months to 3 years with a fever (over 38 °C) who showed signs of shock and had no clear source of infection had blood cultures taken.
Diagnostics
11
15
Insufficient data
FEVE42
Children aged 3 months to 3 years with a fever (over 38 °C) who showed signs of shock and had no clear source of infection had urine sample taken.
Diagnostics
11
15
Insufficient data
FEVE43
Children aged 3 months to 3 years with a fever (over 38 °C) who showed signs of shock and had no clear source of infection but with respiratory symptoms/signs had a chest x-ray taken.
Diagnostics
10
13
Insufficient data
FEVE44
Children aged 3 months to 3 years with a fever (over 38 °C) who showed signs of shock and had no clear source of infection were admitted to hospital for empiric IV antibiotics.
Treatment
10
10
Insufficient data
FEVE45
Children aged 3 months to 3 years with a fever (over 38 °C) who showed signs of shock and had no clear source of infection were admitted to hospital for fluid resuscitation.
Treatment
10
10
Insufficient data
FEVE46
Children with a fever (over 38 °C) where a UTI was suspected had a urine culture taken before commencing antibiotics.
Diagnostics
188
229
71.4 (36.7, 93.7)
FEVE47
Parents of children with a fever (over 38 °C) who were discharged received a fever fact sheet.
Treatment
280
322
30.6 (24.7, 37.0)
GBS Group B Streptococcus, PICU Paediatric Intensive Care Unit, CBE Complete Blood Examination, CRP C-reactive Protein, UTI Urinary Tract Infection
All indicators, except one, examined ‘underuse’ of recommended activities. FEVE29, the exception, measured ‘overuse’; specifically, to prescribe antibiotics for well children aged ≥3 years who had a fever with unknown clinical focus. Adherence was measured at 78.8% for this indicator (95% CI: 51.1–95.0).
When indicators were grouped by phase of care, adherence for Assessment-related indicators averaged 51.3% (95% CI: 48.1–54.6), over 20 percentage points lower than for Diagnostic-related indicators at 77.5% (95% CI: 65.3–87.1) and for Treatment-related indicators at 72.7% (95% CI: 65.3–79.3). Table 3 presents this information further stratified by age-group and it is graphically displayed in Fig. 2. For children under 3 months of age, adherence was 73.4% (95% CI: 58.0–85.8) and for children aged 3–11 months of age, 64.7% (95% CI: 57.0–71.9), both significantly higher than for children aged 4–15 years (53.5%; 95% CI: 50.0–56.9).
Table 3
Average adherence by phase of care and age group, 2012–2013
Phase of care
Age group
No. of childrena
No. of visits
No. of indicators assessed
Proportion adherent, % (95% CI)
Assessment
< 3 months
41
64
1106
68.6 (50.3, 83.5)
3–11 months
107
128
2173
63.0 (55.0, 70.5)
1–3 years
265
338
6058
49.7 (41.4, 58.1)
4–15 years
151
178
3533
46.5 (41.6, 51.5)
Overall
550
708
12,870
51.3 (48.1, 54.6)
Diagnosis
< 3 months
40
61
248
93.5 (85.0, 98.0)
3–11 months
85
102
188
80.0 (63.8, 91.2)
1–3 years
179
227
433
81.4 (68.8, 90.6)
4–15 years
75
89
177
51.2 (23.7, 78.2)
Overall
367
479
1046
77.5 (65.3, 87.1)
Treatment
< 3 months
38
55
88
73.1 (51.2, 89.0)
3–11 months
92
100
196
77.5 (65.8, 86.7)
1–3 years
219
257
503
73.2 (62.5, 82.2)
4–15 years
109
126
176
67.5 (51.5, 80.9)
Overall
446
538
963
72.7 (65.3, 79.3)
All phases
< 3 months
41
64
1442
73.4 (58.0, 85.5)
3–11 months
107
128
2557
64.7 (57.0, 71.9)
1–3 years
265
338
6994
52.3 (44.6, 60.0)
4–15 years
151
178
3886
47.3 (41.7, 52.9)
Overall
550
708
14,879
53.5 (50.0, 56.9)
aThe total number of children is smaller than the sum of the age-groups, as a few children had visits across two or more age-groups during 2012–2013 (e.g., one visit < 3 months of age and another at 8 months of age)
Fig. 2
Average adherence by phase of care and age group, 2012–2013
×
The proportion of adherent care received by children attending an ED was 77.5% (95% CI: 74.2–80.6) and 76.7% (95% CI: 71.7–81.3) for children admitted to hospital, both significantly higher than for children attending a GP (40.3%; 95% CI: 34.6–46.1); see Table 4.
Table 4
Average adherence by setting, 2012–2013
Healthcare setting
No. of childrena
No. of visits
No. of indicators assessed
Proportion adherent % (95% CI)
General Practice
198
217
4322
40.3 (34.6, 46.1)
Emergency Department
342
393
8484
77.5 (74.2, 80.6)
Inpatient
93
98
2073
76.7 (71.7, 81.3)
aThe total number of children is smaller than the sum of the settings, as children admitted to Emergency Departments are sometimes also admitted as inpatients for treatment of the same condition
Anzeige
Discussion
The CTK study was a large-scale survey sampling from 60% of Australia’s paediatric population in three states, including 550 medical record reviews for febrile children presenting to GPs and EDs of general or speciality hospitals or admitted as inpatients. The fever study, as a subset of the broader CTK report [7], examined a cohort of children (0–15 years) where care for fever was documented in their clinical record. Adherence was assessed for 47 indicators derived from CPG guidelines and considered by expert panels to be reflective of best practice. As the study was retrospective, it is not possible to determine whether lack of adherence was because the recommended care was not provided by the clinician at the point of care, or simply not documented in the medical record.
It is reassuring that higher adherence seemed to be directly proportional to the degree of risk of serious underlying disease. For example, for infants < 3 months presenting to ED with a fever (FEVE35–37), appropriateness of care relating to investigations was > 90% for all three indicators. Adherence was higher for infants < 3 months than children aged 4–15 years. Others have commented on the high risk of serious bacterial infections in neonates and infants < 3 months, as well as the relative consistency of both guidelines and practice in these age groups compared to older children [1, 15]. One explanation for the lower adherence for children aged 4–15 years may be that as CPGs are focussed on care for children who are under 5 years old or less [10‐14], clinicians may be less likely to use them as a guide for older children.
We found higher adherence in inpatient and ED settings than for the GP setting. It is possible that these differences reflect the inherent contextual constraints of the GP setting. Time pressures are likely to affect documentation, particularly during the Assessment phase of care when responses are a result of yes/no questioning, and when a negative result is received. There may also be a degree of assumed risk stratification when children and babies are taken to a GP rather than an ED. GPs may not consider the guidelines as reliable or valid for their practice [16] nor may they be aware of their existence [17] as the three Australian guidelines that were used for this study were released by either Departments of Health (in New South Wales [13] and South Australia [14]) or a children’s hospital [12]. None of these were endorsed by recognised GP organisations.
Clinicians were more often adherent with indicators pertaining to the Diagnostics and Treatment phases of care than for the Assessment phase of care (Fig. 2). Considering documentation as a factor in such differences, it may be more likely to be neglected during assessment when it is not an inherent function of the care process, as distinct from ordering tests or prescribing treatment.
Anzeige
The Assessment phase of care incorporated almost half (n = 21) of all 47 clinical indicators included for the fever condition, a bias supported by the literature [1, 2, 18] where emphasis is placed on gathering as much “hands-off’ information as possible about the febrile child. The average adherence during the Assessment phase of fever care exhibited wide variability in our study, ranging from 14.7 to 90.4%. In contrast, the care provided during the Diagnostics phase of care was uniformly high across the eight reported indicators. Over three-quarters of the care provided to children in this phase of care was adherent, with infants < 3 months faring particularly well (> 90% adherence). The Treatment phase of care also yielded higher adherence though no pattern emerges when analysed by age, however it should be noted that there were insufficient data to assess the appropriateness of many of the treatment decisions for infants and for toxic children in older age groups.
Comparison with other studies
An adherence rate of 51.4% (95% CI: 43.2–59.6) was estimated in the 148 eligible children with fever (< 18 years of age) in a USA ambulatory setting, whose care was assessed for 15 indicators [19]. While the overall adherence rate is similar, results at the indicator level were not always directly comparable. For example, in the US study urine cultures were obtained for 16.2% of children 3 to 36 months of age, whereas over 78% of children in the same age group received urine microscopy in our study. Two further studies of febrile infants attending paediatric EDs in the USA, show wide variation in adherence to recommended management for febrile neonates [20], and poor adherence to current guidelines for diagnostic evaluation, particularly for infants aged 60–90 days [15]. Both studies concluded that further research is required to understand the determinants of variability before strategies can be employed to improve adherence.
Guidelines and rules have been developed but consistency and efficacy could improve
CPGs on the management of fever in children have been developed, assessed and revised over several decades by many expert bodies to better guide practitioners in delivering appropriate care [21]. Yet, definitive conclusions on some aspects of fever management remain contested, particularly for children > 28 days, where recommended investigations and thresholds for antibiotic administration vary considerably [22]. A recent international systematic review of guidelines for the symptomatic management of fever in children identified seven common recommendations and ten discordant recommendations–mostly concerning pharmacological approach–from amongst the seven guidelines evaluated using the Appraisal of Guidelines for Research & Evaluation AGREE II tool [21].
Clinical prediction rules and models have also been developed, to improve diagnostic performance in particular [1]. A recent study, comparing four widely used clinical prediction rules and two national guidelines, found that none had perfect diagnostic accuracy and none were considered valuable in ED settings [23]. This lack of consistency and accuracy in the recommended care of children with fever present real challenges for clinicians aiming to deliver high quality care. A computer-assisted diagnostic decision system developed in Australia [18], integrating 40 clinical variables, shows more promise to improve sensitivity and thus early treatment.
Interventions that improve adherence
Even when clinicians are aware of the evidence and are willing to change practice accordingly, altering well established care processes can be difficult without a thorough ‘due diligence’ phase (assessment of barriers and determinants prior to implementation) and a supportive environment conducive to quality improvement [24‐26]. A multifaceted, organisationally relevant approach is necessary, with educational outreach, buy-in and support of both clinicians and executives, underpinned by a systemic, real-time capacity to prompt, monitor, evaluate and feedback on practice [27‐30].
Organisational culture is both a determinant and a product of standardisation of care, adherence to available guidelines and quality improvement [24]. When shared purpose, teamwork and enthusiasm to learn and improve dominate organisational culture, the introduction of standardisation and of evidence-based practice finds fertile ground and far fewer obstacles [31‐35].
Strengths and weakness of the study
There are strengths and limitations to both the overall CTK study [7] and the fever-specific results reported here. Predictably, few febrile children presented directly to specialist paediatrician’s offices, requiring this setting to be removed prior to analysis. This reflects the referral pathways that are in place in Australia where a GP referral is required before a child can be seen in an ambulatory setting by a specialist paediatrician, subsidised by universal insurance.
While hospitals had excellent participation rates, we estimate that around a quarter of GPs were recruited. Accordingly, the potential impact of self-selection bias cannot be excluded, and it may have led to over-estimating adherence.
There were insufficient data to draw any conclusions about the care of neonates, infants and children in the highest risk categories (in shock, unrousable, toxic or showing signs of meningococcal disease), to come to any conclusions on the appropriateness of care for each of these important sub-cohorts. A larger sample size, or a sampling strategy targeting higher risk children, may have overcome this obstacle.
The study assessed processes of care during a visit without distinguishing between primary and subsequent visits for the same febrile episode. The study is therefore unable to provide information on issues such as the frequency of re-visits which may have resulted from missed diagnosis.
Like other studies on appropriateness of care [36, 37], the CTK study utilised medical record review to assess adherence to best practice. Clinicians may, understandably, be more inclined to document aspects of a history that are abnormal or elicit a result of positive value in elucidating the source of fever. We speculate that this may contribute to the lower levels of adherence in the GP setting as well as for the Assessment phase across all provider types. To partially mitigate this weakness, any indicators that the expert panels perceived to be unlikely to be documented were eliminated from the fever set during indicator selection. It is also possible that the opposite may have occurred, and assessments, investigations or treatments were documented without being carried out.
A strength of the study is that it did not restrict the assessment of appropriateness to just one meritorious guideline on fever. Rather, it aimed to assess best practice by selecting common recommendations from a range of reputable guidelines likely to be used by Australian clinicians. Expert groups then validated their inclusion based on acceptability, feasibility, and impact. A further strength of this study was the inclusion of all age ranges and care settings relevant to febrile illness in children.
Conclusions
This study estimated a wide range of documented adherence to 33 indicators for the care of fever by clinicians in Australia. Overall, just over half of the care provided to children with fever was adherent, suggesting the need to further elucidate the reasons why clinicians deviate from best practice.
There are clearly opportunities for improvement, particularly in relation to the documentation of history and clinical assessment of children aged 12 months and over. Our findings suggest that appropriateness of care is relatively high for infants < 3 months of age, for children of all ages who are classified as unwell, and for children aged 3 months to 3 years with no clear source of infection.
Our findings reinforce the need for the adoption of nationally consistent guidelines tailored for the management of fever in childhood across all ages and all healthcare provider settings and regularly updated in line with the changing epidemiology of serious infection in children. Clinician access to such guidance must be quick, reliable and relevant to the care setting. The principle of planning globally whilst acting locally applies well.
Primary ethics approval was received from hospital networks including Sydney Children’s Hospital Network (HREC/14/SCHN/113); Children’s Health Queensland Hospital and Health Service (HREC/14/QRCH/91; Women’s and Children’s Health Network (South Australia) (HREC/14/WCHN/68) and the Royal Australian College of General Practitioners (NREEC 14–008), and site-specific approvals from 34 sites.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Management of fever in Australian children: a population-based sample survey
verfasst von
Joanna Holt Leslie White Gavin R. Wheaton Helena Williams Shefali Jani Gaston Arnolda Hsuen P. Ting Peter D. Hibbert Jeffrey Braithwaite on behalf of the CareTrack Kids investigative team
Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.
Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.
Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.
Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.
Update Pädiatrie
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.
